Patent · US Expired

Methods and apparatus for in vivo identification and characterization of vulnerable atherosclerotic plaques

US6816743B2 · kind B2 · utility

235Cited by
18References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 24, 2001
Grant dateNov 9, 2004
Priority date
Expiry dateJan 11, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2017/22001
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Methods and apparatus for analyzing the chemical composition of vulnerable plaques with an intravascular catheter having a near-infrared light source, a fiber-optic probe, a mechanism for directing the light from the light source into a blood vessel, and detectors for detecting light reflected or scattered by the tissue. The light source may be a tunable laser, and may transmit an incident beam having a wavelength ranging from 1400 to 4100 nm. A computer may be included to receive and process the spectral data in the analysis of the vulnerable plaques. A catheter system may be configured to provide near-IR spectrometric imaging of arteries to non-destructively locate and determine lipid pool and fibrous cap size and composition. Additionally, mediators and cellular components may be also determined that are typically associated with vulnerable plaques which have an increased risk of rupture. The lipid pool, fibrous cap, and inflammatory response may serve as an in vivo marker for vulnerable atherosclerotic plaques. Methods are further provided for prospectively identifying and characterizing vulnerable plaques which may include the steps of focusing near-IR light onto a blood vesse…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.